The outcomes of acute coronary syndrome and complications of acute myocardial infarction in carbohydrate metabolism disorders

Cover Page

Cite item

Full Text

Abstract

Influence of carbohydrate metabolism disturbance depending on expressiveness, degree of severity and type of glucose lowering therapy to current of ischemic heart disease are presented in article. Acute coronary syndrome outcomes to Q-forming and non-Q-forming myocardial infarction, unstable stenocardia, and complications to acute left ventricular aneurysm, frequency of progress pulmonary edema were analyzed in patients with normal and impaired carbohydrate metabolism.

About the authors

S. V Kakorin

Moscow City Hospital №63

канд. мед. наук

L. S Shashkova

Moscow state university of medicine and dentistry named after A.I.Evdokimov

A. M Mkrtumyan

Moscow state university of medicine and dentistry named after A.I.Evdokimov

д-р мед. наук, проф.

I. A Averkova

Moscow state university of medicine and dentistry named after A.I.Evdokimov

References

  1. Майоров А.Ю. Сахарный диабет. 71-й Ежегодный конгресс Американской диабетической ассоциации (ADA). Сан-Диего. 2011; 3: 120–1.
  2. Дедов И.И. Сахарный диабет: развитие технологий в диагностике, лечении и профилактике (пленарная лекция). Сахарный диабет. 2010; 48 (3): 6–13.
  3. Zimmet P, Shaw J, Alberti G. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realisticview. Diabet Мed 2003; 20 (9): 693–702.
  4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Followup report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–7.
  5. Аметов А.С., Соловьева О.Л. Сердечно - сосудистые осложнения при сахарном диабете: патогенез и пути коррекции. РМЖ. Эндокринология. 2011; 27: 1694–9.
  6. Чукаева И.И. и др. Изучение влияния воспаления на прогноз острой кардиоваскулярной патологии. Пути коррекции. Рос. кардиол. журн. 2009; 5: 30–4.
  7. Чазова Т.Е. и др. Роль факторов воспаления в развитии острого коронарного синдрома у пациентов с сахарным диабетом 2-го типа и нарушенной толерантностью к глюкозе. Терапевт. арх. 2007; 79 (6): 60–4.
  8. Selvin E, Bolen S, Yeh H-C et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008; 168 (19): 2070–80.
  9. Malmberg K.A., for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Brit Med J 1997; 314: 1512–5.
  10. Malmberg K, Ryden L, Wedel H et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650–61.
  11. UKPDS Group. Effect of intensive blood - glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998; 352: 854–65.
  12. Аметов А.С., Козедубова И.В. Комбинированная терапия как особенность управления сахарным диабетом типа 2 у кардиальных больных. Болезни сердца и сосудов. 2007; 2 (2): 26–30.
  13. Patel A, MacMahon S, Chalmers J et al. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
  14. Gerstein H.C., Miller M.E., Byington R.P. et al. The Action to Control Cardiovascular Risk in Diabetes Study Group: effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
  15. Duckworth W, Abraira C, Mortiz T et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
  16. Schramm T.K., Gislason G.H., Vaag A. et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J 2011; 32 (15): 1900–8.
  17. Khalangot M, Tronko M, Kravchenko V, Kovtun V. Glibenclamide - related excess in total and ardiovascular mortality risks: data from large Ukrainian observational cohort study. Diabetes Res Clin Pract 2009; 86: 247–53.
  18. Nathan D.M., Buse J.B., Davidson M.B. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association of the study of diabetes. Diabetes Сare 2008; 31: 1–11.
  19. Дедов И.И., Шестакова М.В., Максимова М.А. Федеральная целевая программа «Сахарный диабет». Методические рекомендации. Эндокринологический научный центр РАМН, М., 2007.
  20. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST ЭКГ. Российские рекомендации экспертов ВНОК. М., 2007.
  21. Franklin K, Goldberg R.J. et al. GRACE Investigstors. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004; 164: 1457–63; 47.
  22. Hasada D, Begar et al. A prospective survey on the characteristic, treatment and outcomes of patients with acute coronary syndromes in Europe and Mediterranean basic. The Euro Heart Servey of Acute Coronary Syndromes. Euro Heart J 2002; 23: 1190–201.
  23. Александров А.А. Инфаркт миокарда и сахарный диабет: «Мюнхенский сговор». Болезни сердца и сосудов. 2007; 2 (2): 4–11.
  24. Демидова Т.Ю. Атеросклероз и сахарный диабет типа 2: механизмы и управление. CardioСоматика. 2011; 2.
  25. Johnsen S.P., Monster T.B.M., Olsen M.L. et al. Risk and short - term prognosis of Myocardial infarction among users of antidiabetic drugs. Am J Therapeutics 2006; 13 (2): 134–214.
  26. Сыркин А.Л. Инфаркт миокарда. Медицинское информационное агентство, 1998; с. 88–111.
  27. Kosuge M, Kimura K, Ishikawa J. Present hyperglycemia is associated with left ventricular dysfunction in patients with AMI. Circ J 2005; 69: 23–8.

Copyright (c) 2013 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies